How Big Is the Lyme Disease Market | Growth & Trends 2026

Q: What will the Lyme disease market be worth?

The Lyme disease market is projected to exceed USD 2 billion by 2032, fueled by rising case volumes and improved access to diagnostics and treatments.

Q: What public health factors are influencing the Lyme disease market?

The Lyme disease market is being shaped by climate-driven vector expansion, increased surveillance efforts, and rising awareness through public health initiatives.

Q: How is diagnostics innovation impacting the Lyme disease market?

The Lyme disease market is evolving with AI-backed test interpretation, multiplex panels, and rapid diagnostics enabling earlier and more accurate detection.

Q: Who are the key players in the Lyme disease market?

Key players include Valneva SE, Pfizer Inc., CuraVac Inc., Imugen Inc., and Biopeptides Corp., with Valneva and Pfizer leading vaccine development efforts.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA6978

Publication Date: Jul 2025

How Big Is the Lyme Disease Market?

According to 6Wresearch internal database and industry insights, Global Lyme disease market was valued at USD 1.3 billion in 2025 and is anticipated to surpass USD 2 billion by 2032, progressing at a CAGR of 7.00%.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Global Lyme disease market.

View Main Report Schedule Analyst Call

With the growing incidence of Lyme disease throughout temperate regions, the market is expanding due to increased demand for initial diagnostics, effective long-term treatment options, and awareness programs. Improved serological testing and insurance coverage are also accelerating timely clinical interventions.

Growth Factors of the Lyme Disease Market

A growing incidence of tick-borne illnesses is prompting the need for better diagnostics
Public health awareness campaigns are improving disease awareness and diagnosis
Advancements in molecular tests and antibody-based tests are improving diagnostics
A greater investment in R&D related to vaccines and therapeutics is pushing innovation
Government funding is facilitating more research related to prevention and treatment
Travel and climate changes are increasing the geographic range of disease transmission

Lyme Disease Market Trends

The Lyme disease market is growing in point-of-care diagnostics and at-home testing kits. Precision diagnostics incorporating next-generation sequencing and antigen-capture assays are emerging. There is a demand for telemedicine consultations for initial symptoms, especially in rural and under-recognized areas.

Emerging Developments in the Lyme Disease Market

Within the Lyme disease market, we are still seeing development of vaccine pipelines, especially for high-risk populations in endemic areas. Companies that develop diagnostics have made significant investments into AI-based interpretation tools, as well as multiplex panels to differentiate Lyme disease from co-infections. There also appears to be an increase in collaboration between health authorities and biotechnology companies to develop mass screening projects.